• About us
• Contact

Advertisement

Organisation › Details

X-Pol Biotech S.L

A biotechnology company created by Prof. Luis Blanco and GENETRIX in 2008 with a focus on the development of tools and technologies for the DNA amplification and sequencing market. GENETRIX currently controls 84% of the company. Other shareholders include renowned scientists, Professor Luis Blanco and Professor Margarita Salas. "Qualiphi®" was licensed with the Spanish National Research Council (CSIC) in 2010. *

 

	Start	2008-05-01 established
	Group	2invest (Group)
	Industry	polymerase technology
	Region	Madrid
	Country	Spain (España)
	Street	10–11 Plaza de La Encina Núcleo 1, 3a Planta, Oficina A
	City	28760 Tres Cantos – Madrid
	Tel	+34-91-806-3089
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for 2invest (Group)

• [1] 4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge....
• [2] Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge....
• [3] Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge....
• [4] Sygnis AG. (5/8/18). "Press Release: Sygnis Completes Acquisition of TGR Biosciences". Heidelberg & Cambridge....
• [5] Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg....
• [6] Sygnis AG. (10/18/17). "Press Release: Sygnis AG Announces Completion of Relocation of Its Innova Biosciences Unit to Allow for Expansion". Madrid & Heidelberg....
• [7] Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg....
• [8] Sygnis AG. (6/6/17). "Press Release: Sygnis AG Announces Management and Supervisory Board Changes. Dr. Heikki Lanckriet Sole CEO". Madrid & Heidelberg....
• [9] Sygnis AG. (5/8/17). "Press Release: Sygnis AG Plans to Acquire Profitable Innova Biosciences Ltd. for EUR 8 Million in Cash and up to 3.5 Million Shares [Not for USA, Canada, Japan and Australia]". Madrid & Heidelberg....
• [10] Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.